Ajmera, Veeral

A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes

Ajmera, V., Cepin, S., Tesfai, K., Hofflich, H., Cadman, K., Lopez, S., Madamba, E., Bettencourt, R., Richards, L., Behling, C., et al. (2023) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 327

TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial

Loomba, R., Mohseni, R., Lucas, K. J., Gutierrez, J. A., Perry, R. G., Trotter, J. F., Rahimi, R. S., Harrison, S. A., Ajmera, V., Wayne, J. D., et al. (2021) · Gastroenterology

Liver Disease Diagnosis and TreatmentCancer, Lipids, and Metabolism

Cited by 220

Link between gut‐microbiome derived metabolite and shared gene‐effects with hepatic steatosis and fibrosis in NAFLD

Caussy, C., Hsu, C., Lo, M., Liu, A., Bettencourt, R., Ajmera, V. H., Bassirian, S., Hooker, J., Sy, E., Richards, L., et al. (2018) · Hepatology

Liver Disease Diagnosis and TreatmentGut microbiota and health

Cited by 205

Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study

Huang, D. Q., Wilson, L. A., Behling, C., Kleiner, D. E., Kowdley, K. V., Dasarathy, S., Amangurbanova, M., Terrault, N. A., Diehl, A. M., Chalasani, N., et al. (2023) · Gastroenterology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 190

Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review

Ajmera, V. H., Terrault, N. A., & Harrison, S. A. (2017) · Hepatology

Alcohol Consumption and Health EffectsLiver Disease Diagnosis and Treatment

Cited by 137

Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease

Tamaki, N., Munaganuru, N., Jung, J., Yonan, A. Q., Loomba, R. R., Bettencourt, R., Ajmera, V., Valasek, M. A., Behling, C., Sirlin, C. B., et al. (2022) · Gut

Liver Disease Diagnosis and TreatmentAdvanced MRI Techniques and Applications

Cited by 130

Machine learning enables new insights into genetic contributions to liver fat accumulation

Haas, M. E., Pirruccello, J. P., Friedman, S. N., Wang, M., Emdin, C. A., Ajmera, V. H., Simon, T. G., Homburger, J. R., Guo, X., Budoff, M., et al. (2021) · Cell Genomics

Liver Disease Diagnosis and TreatmentGenetic Associations and Epidemiology

Cited by 118

Emerging role of genomic analysis in clinical evaluation of lean individuals with NAFLD

Vilarinho, S., Ajmera, V., Zheng, M., & Loomba, R. (2021) · Hepatology

Liver Disease Diagnosis and TreatmentGenetic Associations and Epidemiology

Cited by 85

Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women

Ajmera, V. H., Terrault, N. A., VanWagner, L. B., Sarkar, M., Lewis, C. E., Carr, J. J., & Gunderson, E. P. (2019) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentBreastfeeding Practices and Influences

Cited by 75

Alcohol use and cardiovascular disease risk in patients with nonalcoholic fatty liver disease

VanWagner, L. B., Ning, H., Allen, N. B., Ajmera, V., Lewis, C. E., Carr, J. J., Lloyd-Jones, D. M., Terrault, N. A., & Siddique, J. (2017) · Gastroenterology

Alcohol Consumption and Health EffectsLiver Disease Diagnosis and Treatment

Cited by 74

Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease

Tamaki, N., Ahlholm, N., Luukkonen, P. K., Porthan, K., Sharpton, S. R., Ajmera, V., Kono, Y., Dave, S., Ahmed, A., Sundaram, V., et al. (2022) · Journal of Clinical Investigation

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 69